Home NDC 63323-508-01 NDC 63323-508-01 - Meropenem This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 63323-508
Requested NDC 63323-508-01
Package NDCs from labels 63323-508-21, 63323-508-31, 63323-508-45, 63323-508-25, 63323-508-01, 63323-508-30
Manufacturer Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd
Effective date 2021-03-12
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63323-508-21 Meropenem 20 mL in 1 VIAL INJECTION, POWDER, FOR SOLUTION 20 16 63323-508-31 Meropenem 10 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 10 16 63323-508-01 Meropenem 20 mL in 1 VIAL INJECTION, POWDER, FOR SOLUTION 20 15 63323-508-30 Meropenem 10 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 10 15 63323-508-25 Meropenem 25 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 25 11 63323-508-45 Meropenem 20 mL in 1 VIAL INJECTION, POWDER, FOR SOLUTION 20 11
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63323-508 MEROPENEM (MEROPENEM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC
] 16 Current NDC, Legacy NDC, 2 package rows 20210317_12714f80-d6e5-4453-b66c-62f57c16ddfc.zip 63323-508 MEROPENEM (MEROPENEM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC
] 15 Current NDC, Legacy NDC, 2 package rows 20210310_185181e3-c004-4d61-b992-5df94fe57a90.zip 63323-508 MEROPENEM (MEROPENEM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 11 Current NDC, Legacy NDC, 2 package rows 20210316_7a68d899-2678-43a9-a9c1-ef8f916b562f.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MEROPENEM ACTIVE INGREDIENT FV9J3JU8B1 MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 8 MEROPENEM ANHYDROUS ACTIVE MOIETY YOP6PX0BAO MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 8 MEROPENEM ACTIVE INGREDIENT FV9J3JU8B1 MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 5 MEROPENEM ANHYDROUS ACTIVE MOIETY YOP6PX0BAO MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 5 MEROPENEM ACTIVE INGREDIENT FV9J3JU8B1 MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2 MEROPENEM ANHYDROUS ACTIVE MOIETY YOP6PX0BAO MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 23 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.